SCOPUS 정보 검색 플랫폼

American Journal of Psychiatry

Volumn 165, Issue 3, 2008, Pages 396-397

Adjunctive versus monotherapeutic treatment for schizophrenia: Addressing antipsychotic side effects

(3) Hazra, Monica a Mamo, David C a Remington, Gary a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; DRUG SUBSTITUTION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; LETTER; MONOTHERAPY; NEGATIVE SYNDROME; POLYPHARMACY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA; SLEEP; TARDIVE DYSKINESIA; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG COST; ECONOMICS; EXTRAPYRAMIDAL SYNDROME; NOTE;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COSTS; DRUG THERAPY, COMBINATION; HALOPERIDOL; HUMANS; HYPERPROLACTINEMIA; PIPERAZINES; POLYPHARMACY; QUINOLONES; SCHIZOPHRENIA;

EID: 42449152830 PISSN: 0002953X EISSN: None Source Type: Journal
DOI: 10.1176/appi.ajp.2007.07111738 Document Type: Letter

Times cited : (5)

References (9)

1
- 34648833682
- Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: A placebo-controlled trial
- Shim J-C, Shin JG, Kelly DL, Jung DU, Seo YS, Liu KH, Shon JH, Conley RR: Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. Am J Psychiatry 2007; 164:1404-1410
- (2007) Am J Psychiatry , vol.164 , pp. 1404-1410
- Shim, J.-C.¹ Shin, J.G.² Kelly, D.L.³ Jung, D.U.⁴ Seo, Y.S.⁵ Liu, K.H.⁶ Shon, J.H.⁷ Conley, R.R.⁸

2
- 34648830603
- (1A) receptor occupancy in patients with schizophrenia: A triple tracer PET study
- (1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 2007; 164:1411-1417
- (2007) Am J Psychiatry , vol.164 , pp. 1411-1417
- Mamo, D.¹ Graff, A.² Mizrahi, R.³ Shammi, C.M.⁴ Romeyer, F.⁵ Kapur, S.⁶

3
- 32044464964
- Clozapine alone versus clozapine and risperidone with refractory schizophrenia
- Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R: Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med 2006; 354:472-482
- (2006) N Engl J Med , vol.354 , pp. 472-482
- Honer, W.G.¹ Thornton, A.E.² Chen, E.Y.³ Chan, R.C.⁴ Wong, J.O.⁵ Bergmann, A.⁶ Falkai, P.⁷ Pomarol-Clotet, E.⁸ McKenna, P.J.⁹ Stip, E.¹⁰ Williams, R.¹¹ MacEwan, G.W.¹² Wasan, K.¹³ Procyshyn, R.¹⁴

4
- 1642298041
- Aripiprazole-olanzapine combination for treatment of schizophrenia
- Duggal HS: Aripiprazole-olanzapine combination for treatment of schizophrenia. Can J Psychiatry 2004; 49:151
- (2004) Can J Psychiatry , vol.49 , pp. 151
- Duggal, H.S.¹

5
- 0031668084
- Mortality in schizophrenia: Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study
- Waddington JL, Youssef HA, Kinsella A: Mortality in schizophrenia: antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry 1998; 173:325-329
- (1998) Br J Psychiatry , vol.173 , pp. 325-329
- Waddington, J.L.¹ Youssef, H.A.² Kinsella, A.³

6
- 30144446009
- High-cost use of second-generation antipsychotics under California's Medicaid program
- Stahl SM, Grady MM: High-cost use of second-generation antipsychotics under California's Medicaid program. Psychiatr Serv 2006; 57:127-129
- (2006) Psychiatr Serv , vol.57 , pp. 127-129
- Stahl, S.M.¹ Grady, M.M.²

7
- 3042529588
- Focus on antipsychotic polypharmacy: Evidence-based prescribing or prescribing-based evidence?
- Stahl SM: Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? Int J Neuropsychopharmacol 2004; 7:113-116
- (2004) Int J Neuropsychopharmacol , vol.7 , pp. 113-116
- Stahl, S.M.¹

8
- 32944455694
- Augmenting strategies in clozapine-resistant schizophrenia
- Remington G, Saha A, Chong SA, Shammi C: Augmenting strategies in clozapine-resistant schizophrenia. CNS Drugs 2006; 20:171
- (2006) CNS Drugs , vol.20 , pp. 171
- Remington, G.¹ Saha, A.² Chong, S.A.³ Shammi, C.⁴

9
- 9144237416
- Efficacy and safety of aripiprazole vs haloperidol for long-term maintenance treatment following acute relapse of schizophrenia
- Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, Archibald D, Ingenito G, Marcus R, Pigott T: Efficacy and safety of aripiprazole vs haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol 2003; 6:325-337 397
- (2003) Int J Neuropsychopharmacol , vol.6 , Issue.325-337 , pp. 397
- Kasper, S.¹ Lerman, M.N.² McQuade, R.D.³ Saha, A.⁴ Carson, W.H.⁵ Ali, M.⁶ Archibald, D.⁷ Ingenito, G.⁸ Marcus, R.⁹ Pigott, T.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.